The FDA removed semaglutide from the drug shortage list in February 2025 and tirzepatide in October 2024, which restricted 503B outsourcing facilities from large-scale compounding
The Institutes mission is to drive foundational, collaborative, risk-taking research that addresses societys most pressing challenges, including cancer, Alzheimer's disease, and agricultural vulnerability
Wegovy is designed as a long-term weight management treatment
Conditions that affect blood vessels elsewhere in your body also influence your eye complication risk
Other reviewed options include Advanced Bionutritionals GLP-1 Plus , Tranont GLP-1 , RESM GLP-1 Postbiotic , and Replenza GLP-1
Manage with hydration, fiber, activity